Efficacy of Guselkumab in Crohn's Disease

Created using ChatSlide

This presentation offers an insightful overview of Guselkumab's application in treating Crohn's disease. It starts by outlining the challenges of the disease and the importance of IL-23 targeting, followed by the study's goals to assess Guselkumab's efficacy and safety. Attendees will learn about the phase 3 GRAVITI study design, including participant demographics, drug administration methods, and primary outcomes. Key findings highlight remission rates and safety, with comparisons to...